Global Expansion Harness the expanded global footprint from Wallaby Medical's acquisition and rebranding to pursue multi country hospital contracts with a bundled neurovascular solution set including pRESET, p64 MW, p48 MW, pCONUS and HPC coated devices.

Real World Evidence Partner with European centers to participate in the TRUST registry to generate real world evidence on outcomes across stroke modalities, using these data to accelerate hospital adoption and procurement decisions.

Safety Advantage Position Hydrophilic Polymer Coating HPC as a safety differentiator that reduces thrombogenicity across aneurysm and stroke devices, strengthening conversations with centers focused on patient safety, long term outcomes, and device selection.

Portfolio Cross Sell Leverage the exclusive Avenir Coiling System distribution and the full neurovascular portfolio to create bundled offerings for major centers, enabling cross sells from thrombectomy to flow diverters, stents and coils.

Growth Leadership The Enlight Medical merger and new CEO appointment indicate a strategic push for rapid global expansion and broader hospital network coverage; align sales with global accounts and centralized procurement teams.